Tetanus and Diphtheria Toxoids Adsorbed (Td) Shortage

• • Grifols has tetanus and diphtheria toxoids adsorbed (Td) available.[1]
  • Sanofi Pasteur has Tenivac available.[2]
  • Adult tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines are not affected by this shortage.
  • Pediatric diphtheria and tetanus toxoids adsorbed (DT) and diphtheria and tetanus toxoids and acellular pertussis vaccines (DTaP) are not affected by this shortage.

• • Tenivac intramuscular suspension for injection, Sanofi Pasteur, 5 Lf tetanus toxoid / 2 Lf diphtheria toxoid, 0.5 mL syringe, 10 count, NDC 49281-0215-15
  • Tenivac intramuscular suspension for injection, Sanofi Pasteur, 5 Lf tetanus toxoid / 2 Lf diphtheria toxoid, 0.5 mL vial, 10 count, NDC 49281-0215-10
  • Tetanus and Diphtheria Toxoids Adsorbed (Td) intramuscular suspension for injection, Grifols, 2 Lf tetanus toxoid / 2 Lf diphtheria toxoid, 0.5 mL vial, 10 count, NDC 13533-0131-01

Implications for Patient Care

• • Tetanus and diphtheria toxoids adsorbed (Td) is labeled for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age or older. [3-4]

References

• 1. Grifols (personal communications). December 19, 2016; January 31, March 27, May 22, July 7, and September 13, 2017.
  2. Sanofi Pasteur (personal communications). December 19, 2016; January 31, March 27, May 22, July 7 and 21, August 29, and September 13, 2017.
  3. Sanofi Pasteur. Tenivac. Swiftwater, PA; Sanofi Pasteur; April 2013.
  4. Grifols. Tetanus and diphtheria toxoids adsorbed. Los Angeles, CA; February 2015.